Our results indicate that in active SLE, relative to healthy post-immunization responses, blood ASC contain a much larger fraction of newly generated mature CD19− CD138+ ASC similar to bone marrow (BM) LLPC. This evidence concerns the gene CD19 and systemic lupus erythematosus.